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Interleukin-6Abstract Background: Urinary tract infection (UTI) is a common problem that is frequently
encountered by pediatric healthcare providers. Diagnosis of UTI is often difﬁcult, particularly in
critically ill patient and in patients with nonspeciﬁc and mild symptoms. Testing for platelet param-
eters is inexpensive, easily accessible and routinely performed that had been recognized as a hall-
mark in the diagnosis of platelet activation during infection and inﬂammatory disorders.
Aim: To evaluate the value of platelet parameters in the diagnosis of UTI in children in compar-
ison to interleukin-6.
Method: This case–control study included 88 children; 44 of them had culture proved UTI. In
addition 44 age and sex matched healthy children served as a control group. Complete blood picture
with emphasis on platelet parameters (mean platelet volume (MPV), platelet distribution width
(PDW) and platelet count), C-reactive protein, erythrocyte sedimentation rate and interleukin-6
serum levels were done for both groups. We investigated the correlation between platelet parame-
ters, inﬂammatory biomarkers and the type of organism in children with UTI.
Results: Platelet parameters were signiﬁcantly higher in children with UTI in comparison to those
of the control group. There was a signiﬁcant positive correlation between platelet parameters, ESR,
CRP and interleukin-6 in children with UTI. MPV & PDW have 90.1% & 88.6% sensitivity and
86.3% & 84.1% speciﬁcity respectively for diagnosis of UTI. Platelet parameters are signiﬁcantly
higher in children with gram positive infection.
Conclusion: Platelet indices could be used as an indicator of UTI in children. It could predict the
type of causative organism. Further researches are needed to evaluate its role for detection of recur-
rence of UTI in high risk children.
 2016 The Egyptian Pediatric Association. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Urinary tract infections (UTI) are a common and a serious
clinical problem in children. About 8% of girls and 2% of boys
develop at least one episode of acute UTI during childhood.
UTI has been increasingly recognized as an occult cause of feb-
rile illness in infants and young children.1 Upper urinary tract
infections (i.e., pyelonephritis) may lead to renal scarring,
hypertension, and end-stage renal disease.2
The diagnosis of febrile urinary tract infection (UTI) is
often difﬁcult in young children who are not capable of accu-
rately describing their physical problems.3 In young children;
UTI presented with nonspeciﬁc symptoms include discomfort,
fever, poor oral intake, malaise and vomiting.4 Early diagnosis
and prompt antimicrobial treatment are required to minimize
renal scarring and progressive kidney damage.5
The issue of appropriate urine sampling techniques is of
particular concern in young children, where the collection of
a sterile, midstream sample can be problematic. Different
methods of urine sampling may be differently susceptible to
contamination and hence to false positive results.6,7 Suprapu-
bic aspiration has been regarded as the reference standard
collection method which is an invasive procedure that may
require the use of ultrasound guidance. The reference standard
for diagnosis of UTI in children is any bacterial growth of a
urine culture that had been obtained by suprapubic aspiration.
Although urine culture is regarded as the gold standard of
diagnosis, it takes at least 48 h to obtain conﬁrmative results.8
When used alone, urinalysis or blood tests such as
C-reactive protein (CRP) may be inadequate due to their non-
speciﬁc nature.9 In children with UTI, antibiotic treatment
should be initiated as soon as possible to eradicate infection,
prevent bacteremia, improve outcome, and reduce the likeli-
hood of renal involvement.10 This leads to excessive use of
antibiotics with a risk of adverse reactions and bacterial
resistance. To improve diagnosis, alternative more rapid, more
reliable, cost effective diagnostic methods are required.11
Complete blood count is routinely ordered in most patients
with UTI, and information regarding the patient’s platelet
indices is available, easily accessible, without added cost. A
well-prepared peripheral blood ﬁlm can be used for evaluation
of platelet number, size, distribution, and structure under light
microscope. However, with availability of automated cell
counters more precise information can be gathered.12
Platelets are highly complex anucleated cells. They are the
derivatives of bone marrow megakaryocytes. Platelets are
believed to be active participants in the host defense through
phagocytosis and generation of cytotoxic free radicals and
oxidative molecules when activated. Platelets can potentiate
inﬂammatory process by enhancing recruitment of leukocytes
and inhibiting the apoptosis of neutrophils, monocytes, and
eosinophils.13,14
Mean platelet volume (MPV), a parameter routinely
determined by complete blood count analyzers, indicates the
average size of platelets and reﬂects the platelet production
rate and stimulation.15 Platelet distribution width (PDW) is
an indicator of variation in platelet size which reﬂects platelet
activation. Normal values of PDW are between 10% and
17.9%. PDW more than 20% is considered high.16
Although MPV & PDW are not generally taken into con-
sideration by clinicians; they are valuable markers of plateletactivation.17 A higher MPV value is indicative of increased
platelet activity reﬂecting more intense inﬂammation.18 Plate-
let indices had been studied as an inﬂammatory marker in
various diseases19,20 but there are no sufﬁcient data about its
role in the diagnosis of UTI in children.
IL-6 is a multifunctional cytokine with proinﬂammatory
and immunoregulatory functions. It is a key activator of the
acute-phase response and acts on the hypothalamic tempera-
ture regulatory center.21 IL-6 concentrations are considered
as useful diagnostic tools increase early in children with differ-
ent forms of UTI and are higher in patients with acute
pyelonephritis than in those with asymptomatic bacteriuria.22
On the basis of these previous data, we conducted the pre-
sent study to assess whether platelet indices are useful markers
for diagnosis of UTI in children in comparison to acute phase
reactant (ESR & CRP) and IL-6 serum levels. Our hypothesis
is that alteration of the platelet morphology can be a reliable
index for early diagnosis and management of UTI without
waiting for blood culture results. We try to demonstrate a link
between the platelet indices and the type of organism, whether
gram positive or gram negative to allow proper selection of the
empiric antibiotic regimen.
Patients and methods
This prospective case–control study was conducted in pediatric
inpatients and outpatient clinics of Al Hussein, Bab El Sharia
and AL Zahraa university hospitals, Al-Azhar University,
Cairo, Egypt during the period from January 2015 to July
2015. The study included 44 children with culture proved
UTI and 44 age and sex matched healthy children as a control
group. Informed consent was obtained from the participating
children’s parents in adherence to the guidelines of the ethics
committee of AL-Azhar University, Cairo, Egypt.
All children were subjected to the following: Detailed
history and thorough clinical examination. The relevant clini-
cal history includes demographic data, presenting symptoms,
any previous surgery, and current medications. The ﬁndings
of systemic and abdominal examinations were recorded in
detail. The assessment of growth by anthropometric measure-
ments was represented by weight and length/height, which
were plotted on Egyptian growth Charts 200223 to detect
weight for age and height/length for age percentiles. Systolic
and diastolic blood pressure was assessed in all studied
children and plotted on blood pressure chart for age to detect
any deviation from normal expected values for age.24
UTI was diagnosed according to clinical symptoms (fever,
vomiting, anorexia, dysuria, frequency of micturition, abdom-
inal or ﬂank pain) and conﬁrmed by abnormal urine analysis
and positive urine culture.
The following criteria were included in our study: age from
2 years up to 6 years, positive urine culture (urine culture
reviled more than 105 colonies/ml of a single pathogen in a
midstream urine sample). On the other hand we excluded
children with any hematological disorders affecting the platelet
(e.g. Hemolytic anemia, iron deﬁciency anemia, thrombocy-
topenia, and leukemia), those with any concomitant acute or
chronic illness (e.g. diabetes, obesity, hypothyroidism, auto-
immune diseases as ankylosing spondylitis, rheumatoid arthritis,
inﬂammatory diseases as acute appendicitis, ulcerative colitis,
chronic infectious diseases, chronic renal, cardiac, hepatic
144 K.M.S. Zayed et al.diseases) and those who received antibiotic therapy or other med-
ications affecting the platelet count as antihypertensive drugs or
anticoagulants.
Laboratory investigations
Laboratory investigations
Urine analysis. Random urine samples were obtained by either
mid-stream technique or by using sterile urine bag after wash-
ing and cleaning the genitalia and examined within one hour
(physically, chemically aided by Medi Test urine strips and
microscopically).
Urine culture. Another clean urine sample was obtained as
before. Cultures were done on Cled plate, Blood agar plate,
MacConkey and Sabaroud Plates (Oxoid). Yielding plates
were subjected to gram stained ﬁlm, colony count and API
for identiﬁcation. Sensitivity was done on Muller Hinton agar
media.
Blood samples
Five ml of venous blood sample was drawn under complete
aseptic conditions (alcohol swab 70%) in different BD vacu-
tainer’s, (K2 EDTA for CBC, Na Citrate for ESR and plain
gel separator vacutainer for CRP and IL-6).
The plain gel separator vacutainers were kept in a water
bath at 37 C for 30 min then centrifuged at 3500 rpm for
10 min. Serum was aspirated in 2 Eppendorf, one for CRP
assay and the other was stored at -25 C until time of IL-6
assay.
- CBC was performed by Cell Dyne 3700 and SYSMEX
KX21 automated cell counter for measuring and calculat-
ing CBC parameters including mean platelet volume
(MPV) and platelet distribution width (PDW). Blood ﬁlm
was done.
- ESR was done using westergren pipette and reading was
taken at 1st and 2nd hours respectively.
- CRP was assayed using Omega semi quantitative latex kit
(reference range< 6 mg/L).
- Serum IL-6 assay was estimated using commercial ELISA
technique, R&D system Cat No 5060. All frozen aliquots
and refrigerated kits were placed on the bench to thaw to
room temperature. IL-6 standards were reconstituted by
pouring 5.0 ml of calibrator diluent (RD6F) in the lyophi-
lized standards gently and allowed to remain in its place
for 15 min on the bench. After that gentle swirl was done
many times until complete dissolving was conﬁrmed. It
was 330 pg/ml. Five serial calibrator diluted standards were
done (50, 25, 12.5, 6.25, 3.12 pg/ml respectively). 100 ul of
assay diluent (RD1 W) was added to each well except the
ﬁrst well. 100 ul from each calibrator dilutions (6 calibra-
tors) and 88 serum (Patients and control) were added to
each well. The plate was covered and incubated for 2 h at
room temperature. Aspiration and washing four times
using 400 ul volume of the wash buffer were performed.
After each aspiration inversion and blotting against clean
ﬁlter paper was done 200 ul of human Il-6 conjugate was
added to each well. The plate was covered by new supplied
adhesive sheet and incubated for 2 h at room temperature.Aspiration and washing four times using 400 ul volume of
the wash buffer were performed. After each aspiration
inversion, blotting against a clean ﬁlter paper was done.
200 ul of substrate solution was added to each well includ-
ing the ﬁrst plate well. The plate was covered by new sup-
plied adhesive sheet and placed in closed dark cabinet for
20 min. 50 ul of stop solution was added to each well
including the ﬁrst plate well. The plate was gently shaken
to homogenize the content. Reading was done by using
ELISA Tecan sunrise reader adjusted at 540 nm and
570 nm for background. The ﬁrst plate’s well reading was
subtracted from all other readings. The readings (OD) of
the calibrators are plotted on the X axis while the values
are plotted on the Y axis. The concentrations were obtained
by interpolation (reference range< 12.5 pg/ml).
Statistical analysis
Statistical analyses were performed using SPSS version 15 for
Windows software (SPSS Inc., Chicago, IL, USA). The demo-
graphic and clinical properties of patients are expressed using
mean ± SD and percentage values. Differences between
groups were analyzed with the Mann–Whitney U test and
paired t-test. Non parametric data were compared by chi
square test. Correlations between groups were performed using
Spearman correlation coefﬁcients. Receiver operating charac-
teristic curves (ROC) were used to identify sensitivity, speci-
ﬁcity and determine optimal cut-off points of platelet indices
& IL-6 for prediction of UTI. A P-value < 0.05 was consid-
ered to be statistically signiﬁcant.
Results
This study included 44 children with culture proved UTI (16
male and 28 female). In addition, 44 healthy children were
enrolled as a control group (21 male, 23 female). Their age ran-
ged between 2 and 6 years. By urinary culture Gram +ve
organisms were detected in 11/44 (25%) of children with
UTI; which included Enterococci (5 cases) and Staphylococcus
aureus (6 cases), while Gram -ve organisms were detected in
33/44 (%75) of children with UTI; which included Escherichia
coli (24 case), Proteus (7 cases) and Klebsiella (2 cases).
Table 1 shows the general characteristics, clinical data of
the studied children. No age and gender differences were found
among children involved in the study. As regards hematologi-
cal data, children with UTI had signiﬁcantly higher WBCs,
neutrophil% and inﬂammatory biomarker (ESR, CRP, IL-6)
levels than healthy children. The clinical manifestations of
UTI among our studied children are shown in Fig. 1.
Table 2 shows a signiﬁcant increase in platelet count and
indices (MPV & PDW) in children with UTI in comparison
with healthy children. While Table 3 shows a signiﬁcant
increase in platelet indices (MPV & PDW) but not platelet
counts in children with gram positive UTI in comparison to
those with gram negative infection.
Table 3 shows that platelet parameters (MPV & PDW) but
not platelet counts are signiﬁcantly higher in those with gram
positive than those with gram negative urinary tract infection.
Pearson correlation analysis showed a signiﬁcant positive
correlation between platelet count & parameters (MPV &
Table 1 Comparison of clinical and laboratory data of the studied children.
Children with UTI (N= 44) Control group (N= 44) Mann–Whitney/Chi-square test P-value
Age (years) 6.100 ± 2.300 6.401 ± 3.100 0.962 0.337
Sex (male/female) 16/28 21/23 0.681 0.409
Weight (z-score) 0.241 ± 0.852 0.240 ± 1.091 0.031 0.976
Length (z-score) 0.213 ± 1.044 0.214 ± 0.923 0.008 0.994
Systolic Blood pressure (mmHg) 75.332 ± 11.993 71.562 ± 7.520 0.161 0.873
Diastolic blood pressure (mmHg) 59.783 ±± 9.174 57.113 ± 8.281 0.962 0.337
CBC
HB (g/dl) 11.283 ± 1.342 11.482 ± 1.382 0.411 0.683
RBCs (106/mm3) 4.321 ± 1.301 4.103 ± 2.214 1.135 0.259
WBCs (103/mm3) 15.502 ± 3.021 9.403 ± 0.143 5.069 0.000*
Neutrophil % 65.970 ± 14.101 45.285 ± 3.403 2.302 0.021*
CRP (mg/dl) 24 ± 19.651 4 ± 1.801 9.552 0.000*
ESR (1st hour) 35 ± 22.352 12 ± 2.803 8.225 0.000*
IL-6 (ng/dl) 22 ± 7.301 19 ± 7.600 2.297 0.023*
Urine analysis
Pus cells 41.818 ± 16.603 3.863 ± 1.440 15.106 0.000*
RBCS 7.886 ± 3.895 1.545 ± 1.109 10.046 0.000*
UTI: urinary tract infection; CBC: complete blood count; HB: hemoglobin; RBCs: red blood cells; WBCs: white blood cells; CRP: C-reactive
protein; ESR: erythrocyte sedimentation rate; IL-6: interlukin-6.
*Signiﬁcant.
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dren with UTI. Additionally, platelet parameters (MPV &
PDW) had signiﬁcant positive correlations with WBCs count
and neutrophil% in children with UTI (p< 0.05) as demon-
strated in Table 4.
Table 5 shows cut off points, sensitivity and speciﬁcity of
platelet count & parameters (MPV & PDW) and inﬂammatory
markers (ESR, CRP, IL-6) for diagnosis of UTI in children.
Discussion
Rapid assessment is important for proper management deci-
sions in young children with suspected UTI. Platelets, as a part
of the natural immune system, can be elevated as a part of
acute phase reaction during the inﬂammatory process. This
increase in platelets can reﬂect the bone marrow cell activity
in response to proinﬂammatory interleukins, such as IL-1
and IL-6.25,26 As platelets are natural sources of growth factors12
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Figure 1 Histogram showing the clinical manifesincluding platelet-derived growth factor (PDGF), vascular
endothelial growth factor (VEGF), insulin-like growth factor
1 (IGF-1) and transforming growth factor b (TGF-b), they
have an important role in inﬂammation, angiogenesis, repair
and regeneration of tissues.27
Activation of the platelets causes some morphological alter-
ations: the activated platelets seem larger by becoming spheri-
cal in shape and forming pseudopodia. Platelet activation leads
to changes in platelet shape with an increase in platelet swelling
leading to an increase in MPV and PDW.28
Our study demonstrated that children with UTI had a sig-
niﬁcantly higher platelet count and indices (MPV & PDW)
than healthy children. Additionally, there was a signiﬁcant
increase in platelet indices (MPV & PDW) but not platelet
count in children with gram positive UTI in comparison to
those with gram negative infection.
This is in accordance with Catal et al.29 who demonstrated
that the platelet counts were higher in patients with upper UTI38
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tation of children with urinary tract infection.
Table 2 Comparison of platelet count and indices between children with and without UTI.
Children with UTI (N= 44) Control group (N= 44) Mann–Whitney test/Independent T test
t p-value
Platelet count (103/mm3) 489.911 ± 106.320 311.712 ± 115.141 3.760 0.000*
Mean platelet volume (ml) 7.804 ± 0.914 6.503 ± 0.662 2.218 0.000*
Platelet distribution width (%) 17.231 ± 6.572 15.820 ± 4.618 2.420 0.018*
UTI: urinary tract infection; ml: milliliter.
*Signiﬁcant.
Table 3 Comparison of platelet count and indices between children with gram positive and gram negative UTI.
Children with gram
positive infection (N= 11)
Children with gram
negative infection (N= 33)
Mann–Whitney test/Independent T test
t p-value
Platelet count (103/mm3) 512.551 ± 125.298 479.741 ± 98.692 0.793 0.441
Mean platelet volume (ml) 8.454 ± 0.902 7.673 ± 0.673 2.638 0.020*
Platelet distribution width (%) 19.536 ± 4.561 16.071 ± 4.016 2.253 0.039*
UTI: urinary tract infection; ml: milliliter.
*Signiﬁcant.
Table 4 Correlation between platelet parameters and inﬂammatory markers in children with UTI.
MPV PDW Platelet count
r P-value r P-value r P-value
WBCs (103/mm3) 0.340 0.022* 0.376 0.011* 0.225 0.138
Neutrophil% 0.393 0.008* 0.436 0.003* 0.251 0.096
CRP (mg/dl) 0.415 0.005* 0.358 0.017* 0.172 0.023*
ESR (1st hour) 0.484 0.001* 0.491 0.001* 0.194 0.010*
IL-6 (ng/dl) 0.485 0.001* 0.650 0.000* 0.183 0.016*
UTI: urinary tract infection; WBCs: white blood cells; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; IL-6: interlukin-6.
*Signiﬁcant.
Table 5 Sensitivity, speciﬁcity, PPV, NPV of variables for diagnosis of UTI in children.
Cutoﬀ point AUC Sensitivity % Speciﬁcity % PPV % NPV %
Platelet count (103/mm3) 385.8 0.895 86.3 81.8 82.6 85.7
MPV (ml) 7.1 0.930 90.1 86.3 86.9 90.4
PDW (%) 16.42 0.863 88.6 84.1 84.8 88.1
CRP (mg/dl) 4.74 0.594 77.2 68.1 70.8 75
ESR (1st hour) 12.82 0.465 70.4 59.1 63.2 66.7
IL-6 (ng/dl) 25.35 0.640 79.5 72.7 74.5 78
UTI: urinary tract infection; MPV: mean platelet volume; PDW: platelet distribution width; CRP: C-reactive protein; ESR: erythrocyte
sedimentation rate; IL-6: interlukin-6; AUC: area under curve; PPV: positive predictive value; NPV: negative predictive value.
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pared with Gram-negative infections.
Tekin et al.30 had reported thrombocytosis and elevated
MPV & PDW in patients with UTI in comparison to healthy
controls. The platelet counts were similar in children with
upper and lower UTI with no statistically signiﬁcant difference
in MPV values between those with Gram-positive and Gram-
negative infections.
Experimental studies showed that early circulatory responses
to a bolus injection of endotoxin have been correlated with therelease of thromboxane, which incites platelet aggregation.31,32
Both platelet hyperaggregability and peripheral damage/con-
sumption could eventually over 24 h lead to positive feedback
to the bone marrow, resulting in the production of larger and
more active platelets.33
On the other hand, many studies revealed that platelet
count is greatly decreased in severe sepsis (thrombocytopenia)
but this occurred mainly in late stages of sepsis or severe
septicemia as in septic shock due to severe exhaustion of bone
marrow (bone marrow failure).34
Diagnostic value of platelet parameters versus interleukin-6 in children 147As a response to infection, leukocytes and epithelial cells in
the urinary tract produce interleukin IL-6.35 It has been shown
that measurement of IL-6 has a diagnostic value with an ability
to discriminate between cystitis and pyelonephritis.36 IL-6 is an
important pro-inﬂammatory cytokine which could induce
thrombocytosis and affect platelet volume.37,38
Regarding IL-6 our results show a signiﬁcant increase in the
UTI group in comparison with the control group. This is in
agreement with Benson et al.39 who revealed that infections
of the urinary tract activate an IL-6 response which vary with
the severity of infection in children and that cytokine activa-
tion is inﬂuenced by a variety of host and bacterial variables.
Reactive thrombocytosis is usually mediated by an
increased release of numerous cytokines in response to
infections, inﬂammation, vasculitis, tissue trauma, and other
factors. Thrombopoietin (TPO), the primary cytokine for
platelet production and maturation, and interleukin (IL)-6
levels are usually initially elevated in response to the primary
events mentioned earlier; they stimulate an increase in platelet
production. However, serum or plasma levels of these
cytokines do not seem to be correlated with degree of
thrombocytosis.40
Our study has demonstrated a signiﬁcant positive correla-
tion between platelet count & parameters (MPV & PDW)
and inﬂammatory markers (ESR, CRP, IL-6) in children with
UTI. Previous studies had reported a direct relationship
between platelet count and CRP as well as IL-6 during acute
inﬂammation and infections.41,42
The size of the platelet is correlated with the activity and the
function of the platelet; larger platelets are more active than
smaller ones. PDW is an indicator of variation in platelet size,
which can be a sign of active platelet release. MPV has been
reported to be an indirect sign of disturbances in platelet
production and activity of bone marrow response to infection
in both children and adult studies.43
One of the limitations of our study is the small number of
patients. Also, we did not differentiate between upper and
lower UTI. Although dimercaptosuccinic acid (DMSA) renal
scan is the gold standard to differentiate upper from lower
UTI44, this method is costly and exposes children to radioac-
tive chemicals. We did not follow up platelet count and param-
eters in response to treatment. There are no reported data
about the time frame for changes in platelet count and param-
eters with antibiotic therapy so it was invasive to do CBC for
such patients regularly during the course of therapy to evaluate
the response.
Conclusion
MPV and PDW are simple parameters that are provided by
most commercially available automated hematology analyzers.
Using platelet indices to indicate urinary tract infections in
children may be useful adjunctive inﬂammatory markers with
no added cost. Further researches are needed to evaluate its
role in the detection of recurrence of UTI in high risk children.
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